Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE
- PMID: 16971696
- PMCID: PMC4345106
- DOI: 10.1212/01.wnl.0000240853.97716.24
Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE
Abstract
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a multisystemic autosomal recessive disease due to primary thymidine phosphorylase (TP) deficiency. To restore TP activity, we performed reduced intensity allogeneic stem cell transplantations (alloSCTs) in two patients. In the first, alloSCT failed to engraft, but the second achieved mixed donor chimerism, which partially restored buffy coat TP activity and lowered plasma nucleosides. Thus, alloSCT can correct biochemical abnormalities in the blood of patients with MNGIE, but clinical efficacy remains unproven.
Conflict of interest statement
Disclosure: The authors report no conflicts of interest.
Figures
Comment in
-
Treating MNGIE: is reducing blood nucleosides the first cure for a mitochondrial disorder?Neurology. 2006 Oct 24;67(8):1330-2. doi: 10.1212/01.wnl.0000244751.08947.ee. Neurology. 2006. PMID: 17060555 No abstract available.
-
Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE.Neurology. 2007 May 22;68(21):1872; author reply 1872; discussion 1872-3. doi: 10.1212/01.wnl.0000265356.98295.be. Neurology. 2007. PMID: 17515557 No abstract available.
References
-
- Hirano M, Silvestri G, Blake DM, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology. 1994;44:721–727. - PubMed
-
- Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science. 1999;283:689–692. - PubMed
-
- Nishino I, Spinazzola A, Papadimitriou A, et al. MNGIE: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol. 2000;47:792–800. - PubMed
-
- Hirano M, Nishigaki Y, Martí R. MNGIE: a disease of two genomes. Neurologist. 2004;10:8–17. - PubMed
-
- Martí R, Nishigaki Y, Hirano M. Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency. Biochem Biophys Res Commun. 2003;303:14–18. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical